Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2003
06/19/2003WO2003049593A2 Prevention of flap necrosis in plastic surgery
06/19/2003WO2003049559A2 Method of producing a nicotine composition
06/19/2003WO2003049552A2 Beverage treated with nicotine
06/19/2003WO2003049527A2 Mitotic kinesin inhibitors
06/19/2003WO2003039480A3 Method of treating disorder related to high cholesterol concentration
06/19/2003WO2003035002A3 Management of postoperative pain
06/19/2003WO2003028767A3 Water-in-oil emulsions comprising vinyl polymers carrying ethylene oxide groups in side chains, compositions and methods
06/19/2003WO2003028650A3 Benzimidazolidinone derivatives as muscarinic agents
06/19/2003WO2003026572A3 Crystalline forms of ertapenem sodium
06/19/2003WO2003020252A3 Treatment of chronic myelogenous leukemia, resistant or intolerant to sti571, involving homoharringtonine alone or combined with other agents
06/19/2003WO2003013438A3 Nutrient therapy for immuno-compromised patients
06/19/2003WO2003013436A3 Kavalactone compositions and methods of use
06/19/2003WO2003009777A3 Delivery of therapeutic capable agents
06/19/2003WO2003007798A3 Ophthalmic use of 5 fluorourcil
06/19/2003WO2003005960A3 Novel bicyclic and tricyclic cannabinoids
06/19/2003WO2003004096A3 Method and composition for prolonging the residence time of drugs in the gut
06/19/2003WO2003003999A3 Delivery of a bioactive material
06/19/2003WO2002060434A3 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
06/19/2003WO2002048172A3 Diaryl peptides as ns3-serine protease inhibitors of hepatits c virus
06/19/2003WO2002047674A3 Use of intracellular calcium chelators (e.g bapta-am) to increase surfactant secretion in the lungs
06/19/2003WO2002008244A3 Peptides as ns3-serine protease inhibitors of hepatitis c virus
06/19/2003WO2001091696A8 Use of biguanide derivatives for making a medicine having a wound healing effect
06/19/2003WO2001068076A8 D-enantiomer of dfmo and methods of use thereof for treating cancer
06/19/2003WO2001015676A9 Compositions and methods for modulating hdl cholesterol and triglyceride levels
06/19/2003WO2001008635A3 Calcium channel transport polynucleotides, polypeptides, and antibodies
06/19/2003WO2000077000A9 New bispidine compounds useful in the treatment of cardiac arrhythmias
06/19/2003US20030114724 Polyubiquitin based hydrogel and uses thereof
06/19/2003US20030114692 Method for the preparation of citalopram
06/19/2003US20030114683 Novel 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b and v1a arginine-vasopressin receptors
06/19/2003US20030114681 C2-substituted indan-1-ols and their derivatives, processes for their preparation and their use as pharmaceuticals
06/19/2003US20030114678 Cardioprotective phosphonates and malonates
06/19/2003US20030114677 Cardioprotective phosphonates and malonates
06/19/2003US20030114674 2-Hydroxy-mutilin carbamate derivatives for antibacterial use
06/19/2003US20030114672 Purine inhibitors of protein kinases, G proteins and polymerases
06/19/2003US20030114668 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists
06/19/2003US20030114537 Medical combinations comprising mometasone and salmeterol
06/19/2003US20030114536 Venlafaxine hydrochloride monohydrate and methods for the preparation thereof
06/19/2003US20030114535 Reacting dextrochlorpheniramine free base with tannic acid at a temperature of about 60 to 150 degrees C. and recovering the resultant dextrochlorpheniramine tannate; an antihistamine
06/19/2003US20030114534 Pharmaceutical preparation for apthous ulcers
06/19/2003US20030114532 Contacting human or nonhuman animal skin or hair with a compound containing 1-(3-methoxybenzyl)-3-substituted thiourea for for inhibiting free radical degradation
06/19/2003US20030114530 A treatment and/or prevention agent for osteoarthritis comprising N-hydroxy-5-ethoxymethyloxy-2(S)-methyl-4(S)-(4-phenoxybenzoyl)amino pentanamide having an inhibitory activity of matrix metalloproteinases
06/19/2003US20030114529 HO-NH-(C=O)-CH2-CH(-CH2-CH(CH3)2)-(C=O)-V-,V=valine or another amino acid connected with an amino acid sequence of 10 or more amino acids; useful for treating diseases caused by cartilage degradation
06/19/2003US20030114528 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
06/19/2003US20030114527 Administering an immediate release tablets containing 400 mg of 5-methyl-2-(2'- chloro-6'-fluoroanilino)phenylacetic acid or salts to a patient for the treatment of cyclooxygenase-2 mediated diseases
06/19/2003US20030114526 Administration to a human for hair growth a formulation containing a compound selected from lupane triterpenes and derivatives, derivatives of oleanane triterpenes, derivatives of ursane derivatives or salts and mixtures; antialopecia
06/19/2003US20030114525 Method of treating autoimmune diseases
06/19/2003US20030114522 Topical anesthetic
06/19/2003US20030114521 Oxamic acids and derivatives as thyroid receptor ligands
06/19/2003US20030114519 Pharmaceutical combination of bicalutamide and anastrozole for providing an anti-androgenic effect and aromatase inhibition
06/19/2003US20030114518 A conjugated drug with polyamideether copolymer including polylactams and polyether; nontoxic, drug delivery, sustained release
06/19/2003US20030114515 Therapeutic mixture of HMG-COA reductase inhibitors
06/19/2003US20030114514 Preventing collagen-based leukocyte adhesion and leukocyte adhesion
06/19/2003US20030114513 Use of isatin derivatives as ion channel activating agents
06/19/2003US20030114512 Compounds with 5-ht2 and 5-ht1a agonist activity for treating glaucoma
06/19/2003US20030114511 Antitumor agents, a glyoxylamide compounds, drug resistance and metastasizing carcinoma, angiogenesis inhibitors, side effect reduction, nontoxic
06/19/2003US20030114510 Decreasing the membrane depolarization by antagonizing beta amyloid peptide aggregation
06/19/2003US20030114509 Prophylactic or therapeutic drug for renal diseases
06/19/2003US20030114508 Fused imidazolium derivatives
06/19/2003US20030114507 Therapeutic treatment of virus infections; cell antigrowth agents; treating human herpes viruses
06/19/2003US20030114504 Compositions and methods for the treatment of cancer
06/19/2003US20030114503 An imidazolidin-4-one compounds as the Farnesyl transferase inhibitors; anticarcinogenic agents, antiproliferative agents
06/19/2003US20030114499 Antiarrhythmic agents for the treatment and prophylaxis of atrial arrhythmias, atrial fibrillation (AF) or atrial flutter; potassium channel modulators, beta-blocker
06/19/2003US20030114498 A therapeutic agent for cancer-associated neuropathy, comprising a calcium antagonist, a dihydropyridine compounds, nilvadipine
06/19/2003US20030114497 Pharmaceutical compositions of amlodipine and atorvastatin
06/19/2003US20030114494 Storage stability; bioavailability; core containing ndrug, enteric overcoating
06/19/2003US20030114493 Antitumor agents
06/19/2003US20030114492 Method of using neurotrophic sulfonamide compounds
06/19/2003US20030114488 New processes for producing beta-alanine derivatives
06/19/2003US20030114486 Novel quinolinones and uses thereof
06/19/2003US20030114485 Killing drug resistant cancer cells; controlling cell differentiation
06/19/2003US20030114484 Chelated 8-hydroxyquinoline and use thereof in a method of treating epithelial lesions
06/19/2003US20030114483 Synergistic mixture of chromene compound and acetaminophen
06/19/2003US20030114482 Use of retinoid receptor antagonists or agonists in the treatment of cartilage and bone pathologies
06/19/2003US20030114481 Respiratory syncytial virus
06/19/2003US20030114480 Anellated dihydropyridines for the treatment of chronic pain
06/19/2003US20030114478 Asthma therapy; antiinflammatory agents
06/19/2003US20030114477 Rapamycin 29-Enols
06/19/2003US20030114476 High potency dihydroergotamine compositions
06/19/2003US20030114475 Using both drug and behavior modification
06/19/2003US20030114474 Treatment of stereotypic, self-injurious and compulsive behaviors in man and animals using antagonists of NMDA receptors
06/19/2003US20030114473 Anticancer agents
06/19/2003US20030114472 Viricides
06/19/2003US20030114471 Anticancer agent
06/19/2003US20030114470 Crystalline forms of valacyclovir hydrochloride
06/19/2003US20030114469 Combinations
06/19/2003US20030114468 Psychological disorders
06/19/2003US20030114466 Using deoxyguanosine; antcancer agents, autoimmune disease, antiarthritic agents
06/19/2003US20030114465 Substituted imidazole neuropeptide Y Y5 receptor antagonists
06/19/2003US20030114464 Synergistic mixture containing quinolone antibiotic such as floxacin; also fungicide; topical applying to eye
06/19/2003US20030114463 Tetrahydroindolone and purine derivatives linked to arylpiperazines
06/19/2003US20030114462 Drug abruse, alcoholism; respiratory system disorders, cardiovascular disorders
06/19/2003US20030114461 Cyclization 1,4-diazabicyclo(3,2,2)nonane with isooxazole compound
06/19/2003US20030114460 Pharmaceutical conjugates with enhanced pharmacokinetic characteristics
06/19/2003US20030114459 Synergistic mixture with prostaglandins; analgesics
06/19/2003US20030114458 Antibacterial agents
06/19/2003US20030114456 Antiinflammatory agents, analgesics, antipyretics
06/19/2003US20030114455 Sexual disorders
06/19/2003US20030114453 Antiinflammatory agents; asthma; skin disorders
06/19/2003US20030114449 Saccharin derivatives as orally active elastase inhibitors
06/19/2003US20030114446 Induce immunology response
1 ... 5431 5432 5433 5434 5435 5436 5437 5438 5439 5440 5441 5442 5443 5444 5445 5446 5447 5448 5449 5450 5451 ... 7860